[Effect of vasoactive drugs on intra-ocular pressure].
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D009756:Nylidrin / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011817:Rabbits; D014043:Tolazoline / Q000494:pharmacology; D014065:Tonometry, Ocular; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D015016:Yohimbine / Q000494:pharmacology
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D000804:Angiotensin II; D010656:Phenylephrine; D015016:Yohimbine; D002110:Caffeine; D009756:Nylidrin; D014043:Tolazoline; D009638:Norepinephrine; D004837:Epinephrine
Die Wirkung vasoaktiver Pharmaka auf den Augeninnendruck.